BioCentury
ARTICLE | Clinical News

Genfit preclinical data

October 10, 2011 7:00 AM UTC

In a mouse model of NAFLD/NASH, oral GFT505 prevented inflammation and the accumulation of fat, as well as reduced plasma concentrations of alanine aminotransferase (ALT). GFT505 also prevented intra-...